Thermo Fisher Scientific presents cancer research workflow solutions at the AACR Annual Meeting 2022
13 Apr 2022
Thermo Fisher Scientific highlighted a range of molecular technologies and workflows to advance cancer research at the American Association for Cancer Research (AACR) Annual Meeting 2022, held April 8-13, in New Orleans, USA.
The company shared its latest innovations in next generation cellular analysis, precise tumor profiling with digital PCR (dPCR), rapid next generation sequencing (NGS) for cancer variant analysis, and new microarray solutions for precision oncology. Real time PCR(qPCR) solutions to accelerate molecular targets and therapeutic development were also highlighted.
A number of poster presentations covered research areas including the detection of gene fusions and exon skipping events in lung FFPE sample, a novel next-generation sequencing assay for myeloid MRD, and high-throughput NGS solutions for detection of oncology variants, gene fusion events, and key oncology research endpoints.
Learn more about some of the key products highlighted at the conference below:
- Attune CytPix Flow Cytometer
- CellInsight CX7 Pro LZR HCS Platform
- EVOS M5000 Imaging System
- QuantStudio 6 Flex Real-Time PCR System
- HCS NuclearMask Stain
- ProFlex PCR System
Find further coverage of AACR by SelectScience by clicking here >>
